KLEIN JOSEPH III 4
4 · IONIS PHARMACEUTICALS INC · Filed Nov 28, 2025
Insider Transaction Report
Form 4
KLEIN JOSEPH III
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-25+4,000→ 4,000 total(indirect: By Trust) - Sale
Common Stock
2025-11-25$80.00/sh−4,000$320,000→ 0 total(indirect: By Trust) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-25−4,000→ 8,000 total(indirect: By Trust)Exercise: $60.20From: 2021-07-01Exp: 2030-06-30→ Common Stock (4,000 underlying)
Holdings
- 16,346
Common Stock
- 100(indirect: by Son)
Common Stock
Footnotes (3)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 3, 2024
- [F2]The reporting person disclaims beneficial ownership of all securities held in the children's trusts, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F3]The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.